
Retina
Latest News
Advertisement
CME Content
Advertisement

























According to Jeffrey Heier, MD, RGX-314 administered by subretinal injection was well tolerated. In addition, it was associated with dose-dependent increase in ocular protein expression and evidence of clinical benefit.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Comments from the FDA Advisory Committee meeting on SYD-101
2
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
3
FAQ: Diabetic eye disease awareness month 2026
4
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
5










